Test Uniformity of Transdermal Drug Delivery to Breast Using Diclofenac Epolamine
Status:
Completed
Trial end date:
2012-11-12
Target enrollment:
Participant gender:
Summary
The purpose of this study is to look for ways to improve breast cancer treatment by giving
breast cancer drugs through the skin of the breast.
The drug used in this study is a diclofenac epolamine patch and is a nonsteroid
anti-inflammatory pain reliever. The drug amount that gathers in the breast, after
application of a patch to the skin of the breast, will be measured and compared to the amount
that is found in the breast when the patch is applied to the skin of the belly.